Colgate-Palmolive Company 2008 Annual Report

Colgate-Palmolive Company
300 Park Avenue
New York, NY 10022-7499
(212) 310-2000

The common stock of Colgate-Palmolive Company is listed and traded on The New York Stock Exchange under the symbol CL and on other world exchanges including Frankfurt, London, Zurich and Euronext.

The certifications of Colgate’s Chief Executive Officer and Chief Financial Officer, required under Section 302 of the Sarbanes-Oxley Act of 2002, have been filed as exhibits to Colgate’s 2009 Annual Report on Form 10-K. In addition, in 2009, Colgate’s Chief Executive Officer submitted the annual certification to the NYSE regarding Colgate’s compliance with the NYSE corporate governance listing standards.

Our transfer agent can assist you with a variety of shareholder services, including change of address, transfer of stock to another person, questions about dividend checks, direct deposit of dividends and Colgate’s Direct Stock Purchase Plan:

BNY Mellon Shareowner Services
Shareowner Services
PO Box 358015
Pittsburgh, PA 15252-8015
1-800-756-8700 or (201) 680-6685

E-mail: Colgateshareowners@bankofny.com
Web site: www.bnymellon.com/shareowner/isd
Hearing impaired: TDD: 1-800-231-5469

A Direct Stock Purchase Plan is available through BNY Mellon Shareowner Services, our transfer agent. The Plan includes dividend reinvestment options, offers optional cash investments by check or automatic monthly payments, as well as many other features. If you would like to learn more about the Plan or to enroll, please visit the web site indicated above or contact our transfer agent, at 1-800-756-8700 to request a Plan brochure and the forms needed to start the process.

Colgate shareholders are invited to attend our annual meeting. It will be held on Friday, May 7, 2010 at 10:00 a.m. in the Broadway Ballroom of the Marriott Marquis Hotel, Sixth Floor, Broadway at 45th Street, New York, NY. Even if you plan to attend the meeting, please vote by proxy. You may do so by using the telephone, the web site or your proxy card.

PricewaterhouseCoopers LLP

Stockholders and other interested parties are encouraged to communicate directly with the Company’s independent directors by sending an e-mail to directors@colpal.com or by writing to Directors, c/o Office of the General Counsel, Colgate-Palmolive Company, 300 Park Avenue, 11th Floor, New York, NY 10022-7499. Stockholders and other interested parties may also communicate with individual independent directors and committee chairs by writing to them at the above mailing address, in care of the Office of the General Counsel. Such communications are handled in accordance with the procedures described on the Company’s web site.

Financial results, dividend news and SEC filings are available on Colgate’s web site.

Colgate also offers earnings information, dividend news and other corporate announcements toll-free at 1-800-850-2654. The information can be read to the caller and can also be received by mail or fax.

Copies of annual reports, press releases, company brochures, Forms 10-K and other filings and publications are available without charge from the Investor Relations Department:

• by mail, directed to the corporate address
• by e-mail, investor_relations@colpal.com
• by calling 1-800-850-2654 or by calling Investor Relations at (212) 310-2575

Individual investors with other requests:

• please write Investor Relations at the corporate address or
• call (212) 310-2575

Institutional investors:

• call Bina Thompson at (212) 310-3072

You can obtain a copy of Colgate’s World Fact Sheet, Advertising Placement Policy, Product Safety Research Policy, Colgate’s Global Supply Chain, HIV/AIDS Policy, Environmental, Occupational Health & Safety Policy, Colgate’s Global Diversity and Our History by calling Colgate-Palmolive Consumer Affairs at 1-800-468-6502. Colgate: Respecting The World Around Us – Living Our Values For Sustainability and Colgate’s Code of Conduct are available on Colgate’s web site.

For Oral, Personal and Home Care
1-800-468-6502
For Hill’s Pet Nutrition
1-800-445-5777

(212) 310-2199